AIM2 and autoimmune disease: Overall, our study provides a new mechanism by which the innate immune receptor, AIM2, protects against STZ induced-T1D by regulating intestinal homeostasis and inhibiting gut microbiota translocation, events that are strongly associated with the development of autoimmune disorders.